Clinical Trials Logo

Clinical Trial Summary

Aim: The aim of this study was to investigate the clinicopathological factors and to evaluate the prognostic accuracy of the new World Health Organization (WHO) 2017 grading system in pancreatic neuroendocrine tumor (PanNET) patients.

Methods: Data collected between 1997 and December 2017 were analyzed. Histological grading and staging was based on the WHO 2017 grading system. Outcome after surgery and predictors of overall survival (OS) and disease free survival (DFS) were evaluated.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03791346
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date January 1, 1997
Completion date February 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT03000946 - Prevention of Postoperative Pancreatic Fistula by Somatostatin Phase 3
Not yet recruiting NCT03462602 - Nasogastric Tube in Pancreatic Surgery N/A
Recruiting NCT05603702 - STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis Phase 1
Completed NCT04196816 - Surgery for Pancreatic Cancer With Oligo-Metastasis
Recruiting NCT06381362 - Italian Registry of Minimally Invasive Pancreatic Surgery
Completed NCT01059097 - Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy N/A
Withdrawn NCT00671463 - Pancreatic Stent to Prevent Leak After Distal Pancreatectomy N/A